Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2000-5-25
pubmed:abstractText
To investigate the impact of the long-acting bradykinin B2 receptor antagonist HOE 140 (Icatibant) on survival time in a model of severe porcine pancreatitis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0090-3493
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1119-27
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10809293-Acute Disease, pubmed-meshheading:10809293-Adrenergic beta-Antagonists, pubmed-meshheading:10809293-Animals, pubmed-meshheading:10809293-Bradykinin, pubmed-meshheading:10809293-C-Reactive Protein, pubmed-meshheading:10809293-Disease Models, Animal, pubmed-meshheading:10809293-Drug Evaluation, Preclinical, pubmed-meshheading:10809293-Hemodynamics, pubmed-meshheading:10809293-Kinins, pubmed-meshheading:10809293-Pancreatitis, pubmed-meshheading:10809293-Peptides, pubmed-meshheading:10809293-Phospholipases A, pubmed-meshheading:10809293-Phospholipases A2, pubmed-meshheading:10809293-Random Allocation, pubmed-meshheading:10809293-Receptor, Bradykinin B2, pubmed-meshheading:10809293-Receptors, Bradykinin, pubmed-meshheading:10809293-Swine, pubmed-meshheading:10809293-Systemic Inflammatory Response Syndrome, pubmed-meshheading:10809293-Time Factors
pubmed:year
2000
pubmed:articleTitle
Bradykinin B2-receptor antagonism attenuates fatal cardiocirculatory breakdown induced by severe experimental pancreatitis.
pubmed:affiliation
Department of Surgery, University Hospital Eppendorf, Hamburg, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't